Among them, HCC patients with low expression of HDAC1, MAPT, HSP90AA1, and CHGA have a better prognosis, while those with low expression of GHR show the opposite, having a worse prognosis (Figure 8F–J). This evidence concerns the gene GHR and hepatocellular carcinoma.